Sonsuz, A. et al. 2022. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders. Turkish Journal of Gastroenterology. 33, 5 (Jan. 2022), 414–420. DOI:https://doi.org/10.5152/tjg.2022.20844.